7:30 am |
Registration, Continental Breakfast and Visit Exhibits
|
8:20 am |
Welcome and Introductions
Zeina Nahleh, MD
Cleveland Clinic Florida, Weston, Florida |
8:30 am |
Advances in Hormone Receptor-Positive Breast Cancer
Antonio Giordano, MD, PhD
Harvard Medical School, Dana Farber Cancer Institute, Boston, Massachusetts |
9:00 am |
Advances in HER2 Positive Breast Cancer
Ian Krop, MD, PhD
Yale School of Medicine, New Haven, Connecticut |
9:30 am |
Update on Local Therapies and De-escalation Strategies in Breast Cancer Management
Julie E. Lang, MD
Cleveland Clinic, Cleveland, Ohio |
10:00 am |
Break and Visit Exhibits
One Particular Harbor |
10:30 am |
Late-breaking Abstracts and Research in the Pipeline
Hatem Soliman, MD
Moffitt Cancer Center, Tampa, Florida |
11:00 am |
Case Discussions
Elizabeth Stone, MD, Moderator
Cleveland Clinic Florida, Weston, Florida |
12:00 pm |
Lunch and Visit Exhibits
One Particular Harbor |
1:00 pm |
Advances in Triple Negative Breast Cancer
Eleni Andreopoulou, MD
Weill Cornell Medical College, New York, New York |
1:30 pm |
Survivorship Care and Quality of Life updates
Erin Roesch, MD
Cleveland Clinic, Cleveland, Ohio |
2:00 pm |
Update on Biomarkers, Molecular Profiling and cTDNA in Breast Cancer
Massimo Cristofanilli, MD
Weill Cornell Medicine, New York, New York |
2:30 pm |
Novel Therapeutics and AI in Clinical Practice
Shimoli Barot, MD
Cleveland Clinic, Cleveland, Ohio |
3:00 pm |
Closing Remarks
Zeina Nahleh, MD
Cleveland Clinic Florida, Weston, Florida |
3:15 pm |
Adjourn
|
